The technology sector makes up just over a third of the S&P 500 with a 34% weighting. The tech sector includes the three ...

From 1 September, the list price for the most popular and effective weight loss injection (Mounjaro) in the UK will rise by ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Johnson & Johnson said on Thursday it would invest $2 billion in North Carolina as it aims to expand its U.S. manufacturing ...

Wall Street reacted generally positively to the 15% tariff rate cap on pharmaceutical exports from the EU, sending shares of ...

Wall Street reacted generally positively to the 15% tariff rate cap on pharmaceutical exports from the EU, sending shares of ...

The United States and European Union on Thursday released new details of their trade framework, providing clarity on tariffs for sectors including pharmaceuticals, semiconductors, and autos after ...

Pharmaceutical company Eli Lilly responded by issuing a statement that it would raise prices in European countries to “align” them with the costs paid “across developed countries.” So while Europeans ...

The weight-loss obsession is leaving companies with decent prospects in the shade, to the extent that investors should look away from the flashier parts of the pharmaceutical sector to find more ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, potentially illegal tactics that leave observers throwing their hands in the ...

This is an audio transcript of the FT News Briefing podcast episode: ‘What to expect from Jay Powell’s Jackson Hole speech’ Sonja Hutson Good morning from the Financial Times. Today is Wednesday, ...